PAPER Li YC, Chen Q, Wan XZ, Yang XL, Liu X, Zhong L
SEARCH RESULTS
331171 RESULTS
PAPER Ball KA, Phillips AH, Nerenberg PS, Fawzi NL, Wemmer DE, Head-Gordon T
Homogeneous and heterogeneous tertiary structure ensembles of amyloid-β peptides.
Biochemistry. 2011 Sep 6;50(35):7612-28. PubMed: 21797254PAPER Jefferson AL, Gibbons LE, Rentz DM, Carvalho JO, Manly J, Bennett DA, Jones RN
A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition.
J Am Geriatr Soc. 2011 Aug;59(8):1403-11. PubMed: 21797830PAPER McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L
Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial.
J Am Geriatr Soc. 2011 Aug;59(8):1393-402. PubMed: 21797835PAPER Briones A, Gagno S, Martisova E, Dobarro M, Aisa B, Solas M, Tordera R, Ramírez MJ
Stress-induced anhedonia is associated to increased Alzheimer's disease markers.
Br J Pharmacol. 2011 Jul 28; PubMed: 21797840PAPER Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, Parker SJ, Greenough MA, Volitakis I, Adlard PA, Cherny RA, Masters CL, Bush AI, Barnham KJ, White AR
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity.
J Neurochem. 2011 Oct;119(1):220-30. PubMed: 21797865PAPER Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Passmore P, Morgan K, , Younkin SG
Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study.
Mol Neurodegener. 2011;6(1):54. PubMed: 21798052PAPER Zhou F, Gong K, van Laar T, Gong Y, Zhang L
Wnt/β-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity.
Biochem Biophys Res Commun. 2011 Aug 19;412(1):68-73. PubMed: 21798242PAPER Bruce-Keller AJ, Gupta S, Knight AG, Beckett TL, McMullen JM, Davis PR, Murphy MP, Van Eldik LJ, St Clair D, Keller JN
Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.
Neurobiol Dis. 2011 Dec;44(3):317-26. PubMed: 21798347PAPER Liu Y, Hua Q, Lei H, Li P
Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
J Ethnopharmacol. 2011 Sep 2;137(2):1035-46. PubMed: 21798326PAPER Rizzo S, Bisi A, Bartolini M, Mancini F, Belluti F, Gobbi S, Andrisano V, Rampa A
Multi-target strategy to address Alzheimer's disease: design, synthesis and biological evaluation of new tacrine-based dimers.
Eur J Med Chem. 2011 Sep;46(9):4336-43. PubMed: 21798635PAPER Maruszak A, Safranow K, Branicki W, Gawęda-Walerych K, Pośpiech E, Gabryelewicz T, Canter JA, Barcikowska M, Zekanowski C
The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk.
J Alzheimers Dis. 2011 Jan 1;27(1):197-210. PubMed: 21799244PAPER Choi IS, Lee YJ, Choi DY, Lee YK, Lee YH, Kim KH, Kim YH, Jeon YH, Kim EH, Han SB, Jung JK, Yun YP, Oh KW, Hwang DY, Hong JT
4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):127-41. PubMed: 21799245PAPER Didic M, Barbeau EJ, Felician O, Tramoni E, Guedj E, Poncet M, Ceccaldi M
Which memory system is impaired first in Alzheimer's disease?
J Alzheimers Dis. 2011 Jan 1;27(1):11-22. PubMed: 21799246PAPER Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, Lötjönen J,
A disease state fingerprint for evaluation of Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):163-76. PubMed: 21799247Current Filters
No filters selected